These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27863666)

  • 21. Deep vein thrombosis induced by thalidomide to control epistaxis secondary to hereditary haemorrhagic telangiectasia.
    Penaloza A; Vekemans MC; Lambert C; Hermans C
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):616-8. PubMed ID: 21885956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion complexes of chlorzoxazone with β- and hydroxypropyl-β-cyclodextrin: Characterization, dissolution, and cytotoxicity.
    Tang P; Li S; Wang L; Yang H; Yan J; Li H
    Carbohydr Polym; 2015 Oct; 131():297-305. PubMed ID: 26256188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thalidomide for hereditary haemorrhagic telangiectasia.
    Franchini M; Lippi G
    Lancet Haematol; 2015 Nov; 2(11):e457-8. PubMed ID: 26686252
    [No Abstract]   [Full Text] [Related]  

  • 24. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia.
    Buscarini E; Botella LM; Geisthoff U; Kjeldsen AD; Mager HJ; Pagella F; Suppressa P; Zarrabeitia R; Dupuis-Girod S; Shovlin CL;
    Orphanet J Rare Dis; 2019 Feb; 14(1):28. PubMed ID: 30717761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.
    Alderman C; Corlett J; Cullis J
    Br J Haematol; 2013 Aug; 162(4):547-8. PubMed ID: 23672440
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.
    Gavini E; Rassu G; Ferraro L; Beggiato S; Alhalaweh A; Velaga S; Marchetti N; Bandiera P; Giunchedi P; Dalpiaz A
    Eur J Pharm Biopharm; 2013 Feb; 83(2):174-83. PubMed ID: 23153670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical application of timolol decreases the severity and frequency of epistaxis in patients who have previously undergone nasal dermoplasty for hereditary hemorrhagic telangiectasia.
    Ichimura K; Kikuchi H; Imayoshi S; Dias MS
    Auris Nasus Larynx; 2016 Aug; 43(4):429-32. PubMed ID: 26739947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
    Dupuis-Girod S; Pitiot V; Bergerot C; Fargeton AE; Beaudoin M; Decullier E; Bréant V; Colombet B; Philouze P; Faure F; Letievant JC
    Sci Rep; 2019 Aug; 9(1):11986. PubMed ID: 31427745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taking thalidomide out of rehab.
    Akhurst RJ
    Nat Med; 2010 Apr; 16(4):370-2. PubMed ID: 20376039
    [No Abstract]   [Full Text] [Related]  

  • 30. Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis.
    Gomes Dos Reis L; Ghadiri M; Young P; Traini D
    Pharm Res; 2020 Sep; 37(10):186. PubMed ID: 32888133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracorneal melatonin delivery using 2-hydroxypropyl-β-cyclodextrin ophthalmic solution for granular corneal dystrophy type 2.
    Ahn JH; Kim HD; Abuzar SM; Lee JY; Jin SE; Kim EK; Hwang SJ
    Int J Pharm; 2017 Aug; 529(1-2):608-616. PubMed ID: 28694094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intralesional bleomycin injections for the palliation of epistaxis in hereditary hemorrhagic telangiectasia.
    Duncan IC; Van Der Nest L
    AJNR Am J Neuroradiol; 2004 Aug; 25(7):1144-6. PubMed ID: 15313698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posaconazole/hydroxypropyl-β-cyclodextrin host-guest system: Improving dissolution while maintaining antifungal activity.
    Tang P; Ma X; Wu D; Li S; Xu K; Tang B; Li H
    Carbohydr Polym; 2016 May; 142():16-23. PubMed ID: 26917368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal biocompatible powder of Geraniol oil complexed with cyclodextrins for neurodegenerative diseases: physicochemical characterization and in vivo evidences of nose to brain delivery.
    Truzzi E; Rustichelli C; de Oliveira Junior ER; Ferraro L; Maretti E; Graziani D; Botti G; Beggiato S; Iannuccelli V; Lima EM; Dalpiaz A; Leo E
    J Control Release; 2021 Jul; 335():191-202. PubMed ID: 34019946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal timosaponin BII dually sensitive in situ hydrogels for the prevention of Alzheimer's disease induced by lipopolysaccharides.
    Chen W; Li R; Zhu S; Ma J; Pang L; Ma B; Du L; Jin Y
    Int J Pharm; 2020 Mar; 578():119115. PubMed ID: 32045690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and evaluation of synthetic riluzole with β-cyclodextrin and 2,6-di-O-methyl-β-cyclodextrin inclusion complexes.
    Wang L; Li S; Tang P; Yan J; Xu K; Li H
    Carbohydr Polym; 2015 Sep; 129():9-16. PubMed ID: 26050882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of dilution and prolonged storage with preservative in a polyethylene container on Bevacizumab (Avastin™) for topical delivery as a nasal spray in anti-hereditary hemorrhagic telangiectasia and related therapies.
    Kaja S; Hilgenberg JD; Everett E; Olitsky SE; Gossage J; Koulen P
    Hum Antibodies; 2011; 20(3-4):95-101. PubMed ID: 22129679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and evaluation of carfentanil nasal spray employing cyclodextrin inclusion technology.
    Yang P; Li Y; Li W; Zhang H; Gao J; Sun J; Yin X; Zheng A
    Drug Dev Ind Pharm; 2018 Jun; 44(6):953-960. PubMed ID: 29360411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estriol induced squamous metaplasia on the nasal mucosa in patients with hereditary hemorrhagic telangiectasia.
    Sadick H; Bergler WF; Oulmi-Kagermann J; Naim R; Sadick M; Hörmann K; Riedel F
    Arch Med Res; 2005; 36(5):468-73. PubMed ID: 16099323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
    Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
    Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.